Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature

3Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary mucormycosis is rare in systemic lupus erythematosus. A 20-year-old lady with lupus nephritis and neuropsychiatric lupus was treated with injection methylprednisolone and cyclophosphamide. After few days, she developed fever, breathlessness, and hoarseness of voice. After neck and chest imaging, possibility of mucormycosis was considered which was later confirmed on microbiological test. Patient was treated with conventional amphotericin B. Literature review was done, and 8 patients with disseminated or pulmonary mucormycosis were identified with SLE. In patients with high index of suspicion, early imaging can help in diagnosis and early and aggressive management even with conventional amphotericin B can result in favorable outcome.Key Points• Pulmonary mucormycosis in systemic lupus erythematosus is rare.• Radiological investigation can guide towards diagnosis.• Early and aggressive treatment can lead to good outcome.

Cite

CITATION STYLE

APA

Kharbanda, R., Mehndiratta, A., Chatterjee, R., Marak, R. S. K., & Aggarwal, A. (2022, January 1). Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature. Clinical Rheumatology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s10067-021-05941-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free